MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,881,200 | -32.0% | 1,885,000 | 0.0% | 5.55% | -4.9% |
Q2 2023 | $8,652,150 | -45.8% | 1,885,000 | -41.6% | 5.84% | -44.7% |
Q1 2023 | $15,963,750 | -9.3% | 3,225,000 | 0.0% | 10.56% | -10.8% |
Q4 2022 | $17,608,500 | -16.0% | 3,225,000 | 0.0% | 11.83% | +39.8% |
Q3 2022 | $20,963,000 | – | 3,225,000 | – | 8.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |